EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -19.81 Million EUR | -355.88% |
| 2022 | -4.25 Million EUR | -163.92% |
| 2021 | -1.61 Million EUR | -238.16% |
| 2020 | -477 Thousand EUR | -357.84% |
| 2019 | 185 Thousand EUR | 114.07% |
| 2018 | -1.31 Million EUR | 35.13% |
| 2017 | -2.02 Million EUR | -617.09% |
| 2016 | 392 Thousand EUR | -19.67% |
| 2015 | 488 Thousand EUR | 128.11% |
| 2014 | -1.73 Million EUR | 36.99% |
| 2013 | -2.75 Million EUR | -35.71% |
| 2012 | -2.03 Million EUR | 18.7% |
| 2011 | -2.49 Million EUR | -165.4% |
| 2010 | 3.81 Million EUR | 19.24% |
| 2009 | 3.2 Million EUR | -31.92% |
| 2008 | 4.7 Million EUR | 14.84% |
| 2007 | 4.09 Million EUR | 32.38% |
| 2006 | 3.09 Million EUR | 133.98% |
| 2005 | 1.32 Million EUR | 59.46% |
| 2004 | 829.15 Thousand EUR | -89.77% |
| 2003 | 8.1 Million EUR | 69.6% |
| 2002 | 4.78 Million EUR | -6.69% |
| 2001 | 5.12 Million EUR | 36.76% |
| 2000 | 3.74 Million EUR | 146.15% |
| 1999 | -8.11 Million EUR | -232.22% |
| 1998 | 6.13 Million EUR | 850.34% |
| 1997 | -818.18 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -6.17 Million EUR | -26.89% |
| 2024 Q1 | -4.84 Million EUR | -42.83% |
| 2023 Q4 | -3.39 Million EUR | 38.91% |
| 2023 Q1 | -6.55 Million USD | -317.58% |
| 2023 Q3 | -5.55 Million EUR | -31.41% |
| 2023 FY | -19.4 Million EUR | -355.88% |
| 2023 Q2 | -4.22 Million EUR | 35.56% |
| 2022 Q1 | -111 Thousand EUR | -124.08% |
| 2022 FY | -4.25 Million EUR | -163.92% |
| 2022 Q4 | -1.57 Million EUR | 26.94% |
| 2022 Q3 | -2.14 Million EUR | -402.1% |
| 2022 Q2 | -428 Thousand EUR | -285.59% |
| 2021 FY | -1.61 Million EUR | -238.16% |
| 2021 Q4 | 461 Thousand EUR | 124.46% |
| 2021 Q3 | -1.88 Million EUR | -341.45% |
| 2021 Q2 | -427 Thousand EUR | -278.66% |
| 2021 Q1 | 239 Thousand EUR | -86.1% |
| 2020 Q3 | -293 Thousand EUR | -196.7% |
| 2020 Q1 | -1.46 Million EUR | -1948.1% |
| 2020 Q2 | 303 Thousand EUR | 120.75% |
| 2020 FY | -477 Thousand EUR | -357.84% |
| 2020 Q4 | 1.72 Million EUR | 687.03% |
| 2019 Q1 | 208 Thousand EUR | -75.41% |
| 2019 Q2 | 1.65 Million EUR | 695.19% |
| 2019 Q4 | 79 Thousand EUR | -96.28% |
| 2019 FY | 185 Thousand EUR | 114.07% |
| 2019 Q3 | 2.12 Million EUR | 28.23% |
| 2018 Q4 | 846 Thousand EUR | 224.59% |
| 2018 FY | -1.31 Million EUR | 35.13% |
| 2018 Q3 | -679 Thousand EUR | 37.13% |
| 2018 Q2 | -1.08 Million EUR | -168.66% |
| 2018 Q1 | -402 Thousand EUR | -125.84% |
| 2017 Q2 | -430 Thousand EUR | -2.63% |
| 2017 Q4 | -178 Thousand EUR | 82.22% |
| 2017 FY | -2.02 Million EUR | -617.09% |
| 2017 Q1 | -419 Thousand EUR | -225.07% |
| 2017 Q3 | -1 Million EUR | -132.79% |
| 2016 Q4 | 335 Thousand EUR | 200.9% |
| 2016 FY | 392 Thousand EUR | -19.67% |
| 2016 Q2 | -345 Thousand EUR | -147.07% |
| 2016 Q1 | 733 Thousand EUR | -53.72% |
| 2016 Q3 | -332 Thousand EUR | 3.77% |
| 2015 Q2 | -217 Thousand EUR | 65.11% |
| 2015 Q3 | -257 Thousand EUR | -18.43% |
| 2015 Q4 | 1.58 Million EUR | 716.34% |
| 2015 FY | 488 Thousand EUR | 128.11% |
| 2015 Q1 | -622 Thousand EUR | 39.61% |
| 2014 Q2 | -1.6 Million EUR | -387.46% |
| 2014 Q3 | 339 Thousand EUR | 121.13% |
| 2014 Q4 | -1.03 Million EUR | -403.83% |
| 2014 Q1 | 558 Thousand EUR | 146.9% |
| 2014 FY | -1.73 Million EUR | 36.99% |
| 2013 Q3 | -333 Thousand EUR | 77.16% |
| 2013 FY | -2.75 Million EUR | -35.71% |
| 2013 Q1 | -1.19 Million EUR | -570.75% |
| 2013 Q4 | 226 Thousand EUR | 167.87% |
| 2013 Q2 | -1.45 Million EUR | -22.42% |
| 2012 Q4 | 253 Thousand EUR | 174.41% |
| 2012 FY | -2.03 Million EUR | 18.7% |
| 2012 Q3 | -340 Thousand EUR | 63.71% |
| 2012 Q1 | -1 Million EUR | -170.43% |
| 2012 Q2 | -937 Thousand EUR | 6.86% |
| 2011 Q4 | -372 Thousand EUR | -90.77% |
| 2011 Q2 | -1.26 Million EUR | -88.06% |
| 2011 Q1 | -670 Thousand EUR | -81.57% |
| 2011 FY | -2.49 Million EUR | -165.4% |
| 2011 Q3 | -195 Thousand EUR | 84.52% |
| 2010 FY | 3.81 Million EUR | 19.24% |
| 2010 Q4 | -369 Thousand EUR | 53.7% |
| 2010 Q1 | -1.38 Million EUR | -1497.98% |
| 2010 Q2 | -1.26 Million EUR | 8.53% |
| 2010 Q3 | -797 Thousand EUR | 37.05% |
| 2009 Q3 | -1.51 Million EUR | -190.58% |
| 2009 Q1 | -1.26 Million EUR | -195.8% |
| 2009 FY | 3.2 Million EUR | -31.92% |
| 2009 Q4 | 99 Thousand EUR | 106.55% |
| 2009 Q2 | -520 Thousand EUR | 59.02% |
| 2008 Q1 | -1.48 Million EUR | -99.45% |
| 2008 FY | 4.7 Million EUR | 14.84% |
| 2008 Q4 | -429 Thousand EUR | 67.87% |
| 2008 Q3 | -1.33 Million EUR | 9.25% |
| 2008 Q2 | -1.47 Million EUR | 1.18% |
| 2007 Q1 | 4.6 Million EUR | 353.42% |
| 2007 Q2 | 5.95 Million EUR | 29.22% |
| 2007 Q3 | 1.49 Million EUR | -74.92% |
| 2007 FY | 4.09 Million EUR | 32.38% |
| 2007 Q4 | -746.34 Thousand EUR | -150.0% |
| 2006 Q1 | -480.98 Thousand EUR | 92.03% |
| 2006 Q4 | -1.81 Million EUR | -141.74% |
| 2006 Q3 | -751.71 Thousand EUR | 12.28% |
| 2006 Q2 | -856.94 Thousand EUR | -78.17% |
| 2006 FY | 3.09 Million EUR | 133.98% |
| 2005 Q2 | 1.59 Million EUR | -2.32% |
| 2005 Q1 | 1.62 Million EUR | 127.3% |
| 2005 FY | 1.32 Million EUR | 59.46% |
| 2005 Q4 | -6.03 Million EUR | -518.3% |
| 2005 Q3 | 1.44 Million EUR | -9.29% |
| 2004 Q1 | 5.65 Million EUR | 154.98% |
| 2004 Q4 | -5.96 Million EUR | -419.29% |
| 2004 Q2 | 1.64 Million EUR | -70.98% |
| 2004 FY | 829.15 Thousand EUR | -89.77% |
| 2004 Q3 | 1.86 Million EUR | 13.82% |
| 2003 Q3 | 599.63 Thousand EUR | -24.76% |
| 2003 Q1 | 842.94 Thousand EUR | 110.38% |
| 2003 Q2 | 796.97 Thousand EUR | -5.45% |
| 2003 Q4 | -10.28 Million EUR | -1815.37% |
| 2003 FY | 8.1 Million EUR | 69.6% |
| 2002 Q4 | -8.12 Million EUR | -1094.09% |
| 2002 FY | 4.78 Million EUR | -6.69% |
| 2002 Q3 | 817.21 Thousand EUR | -81.78% |
| 2002 Q2 | 4.48 Million EUR | -11.09% |
| 2002 Q1 | 5.04 Million EUR | 123.78% |
| 2001 Q3 | 5.21 Million EUR | -18.2% |
| 2001 Q2 | 6.38 Million EUR | 7.76% |
| 2001 Q1 | 5.92 Million EUR | 124.52% |
| 2001 FY | 5.12 Million EUR | 36.76% |
| 2001 Q4 | -21.21 Million EUR | -506.45% |
| 2000 Q3 | 7.93 Million EUR | 33.65% |
| 2000 Q1 | 5.55 Million EUR | 124.16% |
| 2000 Q2 | 5.93 Million EUR | 6.91% |
| 2000 FY | 3.74 Million EUR | 146.15% |
| 2000 Q4 | -24.15 Million EUR | -404.34% |
| 1999 Q2 | 4.82 Million EUR | -18.77% |
| 1999 FY | -8.11 Million EUR | -232.22% |
| 1999 Q1 | 5.94 Million EUR | 126.71% |
| 1999 Q4 | -22.98 Million EUR | -646.2% |
| 1999 Q3 | 4.2 Million EUR | -12.85% |
| 1998 Q3 | 3.73 Million EUR | -48.11% |
| 1998 Q1 | 6.12 Million EUR | 126.23% |
| 1998 FY | 6.13 Million EUR | 850.34% |
| 1998 Q4 | -22.26 Million EUR | -696.25% |
| 1998 Q2 | 7.19 Million EUR | 17.41% |
| 1997 Q3 | 8.2 Million EUR | 81.28% |
| 1997 Q4 | -23.36 Million EUR | -384.69% |
| 1997 FY | -818.18 Thousand EUR | 0.0% |
| 1997 Q1 | 4.56 Million EUR | 0.0% |
| 1997 Q2 | 4.52 Million EUR | -0.91% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alphatec Holdings, Inc. | -173.39 Million USD | 88.573% |
| Nemaura Medical Inc. | -9.59 Million USD | -106.488% |
| NeuroPace, Inc. | -27.17 Million USD | 27.088% |
| LENSAR, Inc. | -12.22 Million USD | -62.017% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 64.972% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 63.411% |
| Apyx Medical Corporation | -17.25 Million USD | -14.798% |
| Cutera, Inc. | -156.23 Million USD | 87.318% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -130.277% |
| BioSig Technologies, Inc. | -28.51 Million USD | 30.51% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 63.328% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 117.765% |
| Axonics, Inc. | -26.05 Million USD | 23.963% |
| IRIDEX Corporation | -10 Million USD | -97.991% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 81.851% |
| TELA Bio, Inc. | -44.07 Million USD | 55.047% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -140.303% |
| RxSight, Inc. | -50.08 Million USD | 60.441% |
| Align Technology, Inc. | 643.33 Million USD | 103.08% |
| INVO Bioscience, Inc. | -6.76 Million USD | -192.782% |
| electroCore, Inc. | -18.8 Million USD | -5.36% |
| Telesis Bio, Inc. | -35.15 Million USD | 43.633% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 238.262% |
| Quipt Home Medical Corp. | 3.91 Million USD | 605.563% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 77.392% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -63.298% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 59.133% |
| Dynatronics Corporation | -2.27 Million USD | -771.649% |
| Modular Medical, Inc. | -17.52 Million USD | -13.03% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -35.344% |
| Talis Biomedical Corporation | -66.81 Million USD | 70.346% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -86.54% |
| InMode Ltd. | 195.66 Million USD | 110.126% |
| Envoy Medical, Inc. | -18.37 Million USD | -7.849% |
| Bruker Corporation | 436.9 Million USD | 104.535% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -59.422% |
| DexCom, Inc. | 597.7 Million USD | 103.315% |
| Nexalin Technology, Inc. | -5.69 Million USD | -247.823% |
| PAVmed Inc | -68.79 Million USD | 71.2% |
| Viveve Medical, Inc. | -21.55 Million USD | 8.073% |
| Cerus Corporation | -30.05 Million USD | 34.073% |
| Movano Inc. | -29.69 Million USD | 33.267% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 28.845% |
| Nexalin Technology, Inc. | -5.69 Million USD | -247.823% |
| IceCure Medical Ltd | -15.57 Million USD | -27.202% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 91.505% |
| enVVeno Medical Corporation | -25.23 Million USD | 21.495% |
| 908 Devices Inc. | -42.75 Million USD | 53.662% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 11.73% |
| Orthofix Medical Inc. | -139.11 Million USD | 85.757% |
| Surmodics, Inc. | -5.64 Million USD | -250.983% |
| Nuwellis, Inc. | -17.63 Million USD | -12.382% |
| Outset Medical, Inc. | -169.77 Million USD | 88.33% |
| Venus Concept Inc. | -28.3 Million USD | 30.012% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 84.17% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 61.474% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 68.344% |
| Aethlon Medical, Inc. | -12.63 Million USD | -56.791% |
| Inogen, Inc. | -109.38 Million USD | 81.887% |
| IRadimed Corporation | 20.03 Million USD | 198.89% |
| MaxCyte, Inc. | -48.29 Million USD | 58.978% |
| Pulmonx Corporation | -61.93 Million USD | 68.01% |
| PAVmed Inc. | -68.79 Million USD | 71.2% |
| iCAD, Inc. | -7.68 Million USD | -157.68% |
| OrthoPediatrics Corp. | -25.76 Million USD | 23.104% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -461.593% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -14.738% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -65.726% |
| SI-BONE, Inc. | -46.93 Million USD | 57.783% |
| Semler Scientific, Inc. | 22.25 Million USD | 189.023% |
| Beyond Air, Inc. | -63 Million USD | 68.554% |
| FONAR Corporation | 16.53 Million USD | 219.822% |
| AxoGen, Inc. | -21.46 Million USD | 7.683% |
| Biotricity, Inc. | -8.82 Million USD | -124.427% |
| Cytosorbents Corporation | -31.2 Million USD | 36.516% |
| ZimVie Inc. | -30.93 Million USD | 35.961% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 209.822% |
| Inari Medical, Inc. | -14.03 Million USD | -41.199% |
| UFP Technologies, Inc. | 57.66 Million USD | 134.359% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -461.593% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -302.082% |
| Sight Sciences, Inc. | -57.27 Million USD | 65.407% |
| Insulet Corporation | 220 Million USD | 109.006% |
| Profound Medical Corp. | -28.61 Million USD | 30.763% |
| Bioventus Inc. | -81.72 Million USD | 75.757% |
| InspireMD, Inc. | -21.14 Million USD | 6.29% |
| BrainsWay Ltd. | -4.92 Million USD | -302.131% |
| BIOLASE, Inc. | -17.93 Million USD | -10.459% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -214.204% |
| Tenon Medical, Inc. | -15.72 Million USD | -25.981% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -165.092% |
| CVRx, Inc. | -43.1 Million USD | 54.033% |
| AdaptHealth Corp. | -598.4 Million USD | 96.689% |
| Sintx Technologies, Inc. | -13.35 Million USD | -48.323% |
| Acutus Medical, Inc. | -14.36 Million USD | -37.964% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -14.552% |
| NanoVibronix, Inc. | -3.43 Million USD | -476.63% |
| Quanterix Corporation | -49.7 Million USD | 60.136% |
| LivaNova PLC | -68.49 Million USD | 71.075% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 53.606% |
| Varex Imaging Corporation | 32.1 Million USD | 161.723% |
| Vivani Medical, Inc. | -26.96 Million USD | 26.523% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -63.298% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -5086.649% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 94.076% |
| TransMedics Group, Inc. | -28.72 Million USD | 31.03% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 16.089% |
| NeuroMetrix, Inc. | -7.15 Million USD | -177.046% |
| Spectral AI, Inc. | -12.98 Million USD | -52.596% |
| Hyperfine, Inc. | -48.11 Million USD | 58.822% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 69.531% |
| Biomerica, Inc. | -6.36 Million USD | -211.183% |
| Bone Biologics Corporation | -9.42 Million USD | -110.144% |
| AVITA Medical, Inc. | -40.4 Million USD | 50.96% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -92.15% |
| Silk Road Medical, Inc | -59.27 Million USD | 66.572% |